Lexington BioSciences (CSE: LNB) (OTC: LXGTF), introduces HeartSentry, a revolutionary, simple and effective technology for personalized measurement and monitoring of vascular health to detect the potential for cardiovascular disease at its earliest stages. The device is designed to measure the function of the endothelium, the cells that line all arteries and are critical to the prevention of atherosclerosis, heart attacks and stroke.

https://player.vimeo.com/video/183611304